Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

In vitro antifungal susceptibility profile and correlation of mycelial and yeast forms of molecularly characterized Histoplasma capsulatum strains from India.

Kathuria S, Singh PK, Meis JF, Chowdhary A.

Antimicrob Agents Chemother. 2014 Sep;58(9):5613-6. doi: 10.1128/AAC.02973-14. Epub 2014 Jun 30.

2.

Histoplasmosis infection in patients with rheumatoid arthritis, 1998-2009.

Olson TC, Bongartz T, Crowson CS, Roberts GD, Orenstein R, Matteson EL.

BMC Infect Dis. 2011 May 23;11:145. doi: 10.1186/1471-2334-11-145.

3.

Detection of histoplasma antigen by a quantitative enzyme immunoassay.

Connolly PA, Durkin MM, Lemonte AM, Hackett EJ, Wheat LJ.

Clin Vaccine Immunol. 2007 Dec;14(12):1587-91. Epub 2007 Oct 3.

4.

Efficacy of ravuconazole in treatment of systemic murine histoplasmosis.

Clemons KV, Martinez M, Calderon L, Stevens DA.

Antimicrob Agents Chemother. 2002 Mar;46(3):922-4.

5.

Antigen clearance during treatment of disseminated histoplasmosis with itraconazole versus fluconazole in patients with AIDS.

Wheat LJ, Connolly P, Haddad N, Le Monte A, Brizendine E, Hafner R.

Antimicrob Agents Chemother. 2002 Jan;46(1):248-50.

6.

Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice.

Connolly P, Wheat LJ, Schnizlein-Bick C, Durkin M, Kohler S, Smedema M, Goldberg J, Brizendine E, Loebenberg D.

Antimicrob Agents Chemother. 2000 Oct;44(10):2604-8.

Supplemental Content

Support Center